Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary

Seegene Inc. , South Korea's leading molecular diagnostics company, announced the appointment of Dr. Glen Hans...

March 18, 2022 | Friday | News
Korea designs hair-thin patch for measuring pulse waves

A team of scientists at the Pohang University of Science and Technology (POSTECH) in South Korea has developed a wearabl...

March 17, 2022 | Thursday | News
RedHill inks deal worth $6M with Kukbo for COVID-19 drug in South Korea

RedHill Biopharma has entered into an exclusive license agreement with Kukbo Co., a South Korean corporation, for o...

March 16, 2022 | Wednesday | News
DEKRA inks MoU with Korea Testing Laboratory

DEKRA has signed the Memorandum of Understanding (MoU) with Korea Testing Laboratory (KTL) to develop cooperation opport...

March 16, 2022 | Wednesday | News
South Korea lays focus on novel mRNA therapeutics

NuclixBio Inc., a South Korean biotech company that focuses on research and development of mRNA therapeutics, has signed...

March 15, 2022 | Tuesday | News
Innovations in APAC have become cornerstone of future development of IVD

PerkinElmer has made a number of acquisitions in life sciences and diagnostics as well as R&D investments with accel...

March 15, 2022 | Tuesday | Opinion
Everest Medicines offers treatment for primary IgA nephropathy in South Korea

Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical p...

March 14, 2022 | Monday | News
Korea develops smart LED contact lenses for treating diabetic retinopathy

A research team at South Korea-based Pohang University of Science and Technology (POSTECH), in collaboration with Dr San...

March 10, 2022 | Thursday | News
Medical Korea 2022 focuses on future directions of global healthcare industry

Medical Korea 2022 will be held on March 10 and 11 at the Korea International Exhibition and Convention Center (Coe...

March 9, 2022 | Wednesday | News
Korea reinforces strategic focus on fibrotic diseases

Bridge Biotherapeutics, a South Korean clinical-stage biotechnology company focused on developing novel drugs for fibros...

March 8, 2022 | Tuesday | News
South Korea's Aston Sci. raises $22.7 M in Series C

South Korea-based startup Aston Sci. has announced the completion of the Series C funding at a scale of $22.7 milli...

March 4, 2022 | Friday | News
Korea's Genome and Company partners with Merck for cancer drug trial

Genome and Company, a leading global microbiome anti-cancer drug development company in Korea, has entered into a first ...

March 4, 2022 | Friday | News
Korea's GC Labs partners with firms in Middle East and Cambodia

GC Labs,  the leading clinical diagnostics company in Korea, has  announced the new lab testing service a...

March 3, 2022 | Thursday | News
Korea's Seegene appoints new CEO for its US subsidiary

Seegene Inc., South Korea's leading molecular diagnostics company, has announced the appointment of Dr. Richard S. ...

March 3, 2022 | Thursday | News
Korea suggests disinfecting COVID-19 with plasma filter

A research team led by Nano-Bio Convergence at the Korea Institute of Materials Science (KIMS) succeeded in develop...

March 2, 2022 | Wednesday | News
Korea-based GI Innovation strengthens focus on next-gen innovative immuno-oncology

GI Innovation, based in South Korea, has signed a biomarker joint research MoU with CellKey, a Glycoprotein biomarker de...

February 28, 2022 | Monday | News
WHO establishes global bio-manufacturing training hub in Korea

The World Health Organization (WHO), the Republic of Korea and the WHO Academy have announced the establishment of a glo...

February 25, 2022 | Friday | News
Korea develops electronic skin that can feel in real time

A research team at Pohang University of Science and Technology in South Korea, in collaboration with the Department...

February 23, 2022 | Wednesday | News